The Clinical Benefit of the Modified Neutrophil-Platelet Score as a Surrogate Prognostic Marker in Patients With Resectable Gastric Cancer.
Otani K, Aoyama T, Maezawa Y, Hashimoto I, Kamiya N, Kato A, Numata M, Kawahara S, Tamagawa A, Nakazono M, Tamagawa H, Segami K, Kazama K, Sawazaki S, Yukawa N, Saito A, Rino Y.
Otani K, et al. Among authors: tamagawa h.
In Vivo. 2024 Mar-Apr;38(2):897-903. doi: 10.21873/invivo.13516.
In Vivo. 2024.
PMID: 38418135
Free PMC article.